January 19, 2026
Male Factor Infertility: 5 Tests & Treatments You Need to Know
Male factor infertility contributes to 40-50% of all infertility cases, often identified through a semen analysis evaluating volume, count, motility, and morphology. Treatments include IUI, IVF with ICSI, and surgical sperm retrieval for severe cases.
Key Takeaways
Understanding Semen Analysis Parameters for Male Infertility Diagnosis
A semen analysis evaluates four key parameters: volume (minimum 1.5ml), sperm count (>20 million/mL), motility (≥40% moving), and morphology (>4% normal shape). Abnormal results can indicate production issues, blockages, or environmental factors affecting fertility.
Intrauterine Insemination (IUI) for Mild Male Infertility: What You Need to Know
IUI is a low-cost, non-invasive treatment for mild male infertility. It involves washing and concentrating sperm before direct uterine placement. While effective for low-severity cases, success rates are significantly lower than IVF with ICSI (up to 53% pregnancy rate for IVF/ICSI).
Surgical Sperm Retrieval Options for Non-Obstructive Azoospermia
For men with no sperm in ejaculate (azoospermia), procedures like PESA/TESE or testicular biopsy can extract sperm for IVF. These outpatient surgeries require local/general anesthesia and have a quick recovery, with retrieved sperm usable in multiple treatment cycles when frozen.
Choosing Certified Sperm Banks for Donor Sperm Treatments
20% of IUI cycles use donor sperm, especially for same-sex couples or severe male infertility. Reputable sperm banks like Xytex Cryo and California Cryobank screen for infectious diseases, genetic disorders, and sperm quality to ensure safety and viability.
FDA-Regulated Sperm Donor Screening Protocols for Safety and Success
Both anonymous and known sperm donors must undergo 6-month quarantine, infectious disease testing (HIV, Hepatitis), and genetic screening for conditions like cystic fibrosis. This ensures donor sperm meets FDA standards and minimizes health risks for recipients.
Source: Read full article